The Asia Pacific Neurocognitive Assessment And Rehabilitation Market would witness market growth of 9.2% CAGR during the forecast period (2023-2030).
The market play a pivotal role in the diagnosis and management of various neurological disorders, including Alzheimer's disease, Parkinson's disease, multiple sclerosis, and traumatic brain injuries. Early detection and targeted interventions can slow down the progress of these diseases and improve overall quality of life. The intersection of neurocognitive assessment and mental health is gaining attention, with applications in conditions such as depression, anxiety, and schizophrenia. Understanding the cognitive underpinnings of mental health disorders allows for more comprehensive treatment approaches that address both cognitive and emotional aspects.
In the realm of sports medicine, neurocognitive assessment is increasingly employed for the management of concussions. Baseline testing and subsequent assessments help determine the extent of cognitive impairment following a head injury, guiding return-to-play decisions and ensuring the athlete's long-term cognitive well-being. With an aging population, there is a growing focus on age-related cognitive deterioration, such as mild cognitive impairment and dementia. Early detection and targeted interventions can mitigate cognitive decline and enhance cognitive resilience in older adults.
According to the National Library of Medicine report updated in 2023, as many previous studies have indicated, Parkinson's disease (PD) increases rapidly once the age of 50 is reached and peaks at around 80. The proportion of people in China over 65 is estimated to reach 23.9–26.9% in 2050. Furthermore, according to Invest India, the telemedicine industry is India's maximum potential eHealth segment, expected to reach $5.4 Bn by 2025. Due to the aforementioned factors the market growth will drive in this region.
The China market dominated the Asia Pacific Neurocognitive Assessment And Rehabilitation Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $1,781.9 Million by 2030. The Japan market is registering a CAGR of 8.5% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 9.9% during (2023 - 2030).
Based on Component, the market is segmented into Neurorehabilitation Therapy, and Neurocognitive Assessment Testing. Based on Providers, the market is segmented into Rehab Centers, Hospital & Clinics, Homecare Settings, and Physiotherapy Centers. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Cambridge Cognition Holdings plc, Cognifit, Inc., Cogstate Ltd., Lumos Labs, Inc. (Lumosity), CNS Vital Signs, LLC, Posit Science Corporation, BrainCheck, Inc., Constant Therapy Health, NeuronUP SL and SCHUHFRIED GmbH
The market play a pivotal role in the diagnosis and management of various neurological disorders, including Alzheimer's disease, Parkinson's disease, multiple sclerosis, and traumatic brain injuries. Early detection and targeted interventions can slow down the progress of these diseases and improve overall quality of life. The intersection of neurocognitive assessment and mental health is gaining attention, with applications in conditions such as depression, anxiety, and schizophrenia. Understanding the cognitive underpinnings of mental health disorders allows for more comprehensive treatment approaches that address both cognitive and emotional aspects.
In the realm of sports medicine, neurocognitive assessment is increasingly employed for the management of concussions. Baseline testing and subsequent assessments help determine the extent of cognitive impairment following a head injury, guiding return-to-play decisions and ensuring the athlete's long-term cognitive well-being. With an aging population, there is a growing focus on age-related cognitive deterioration, such as mild cognitive impairment and dementia. Early detection and targeted interventions can mitigate cognitive decline and enhance cognitive resilience in older adults.
According to the National Library of Medicine report updated in 2023, as many previous studies have indicated, Parkinson's disease (PD) increases rapidly once the age of 50 is reached and peaks at around 80. The proportion of people in China over 65 is estimated to reach 23.9–26.9% in 2050. Furthermore, according to Invest India, the telemedicine industry is India's maximum potential eHealth segment, expected to reach $5.4 Bn by 2025. Due to the aforementioned factors the market growth will drive in this region.
The China market dominated the Asia Pacific Neurocognitive Assessment And Rehabilitation Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $1,781.9 Million by 2030. The Japan market is registering a CAGR of 8.5% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 9.9% during (2023 - 2030).
Based on Component, the market is segmented into Neurorehabilitation Therapy, and Neurocognitive Assessment Testing. Based on Providers, the market is segmented into Rehab Centers, Hospital & Clinics, Homecare Settings, and Physiotherapy Centers. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Cambridge Cognition Holdings plc, Cognifit, Inc., Cogstate Ltd., Lumos Labs, Inc. (Lumosity), CNS Vital Signs, LLC, Posit Science Corporation, BrainCheck, Inc., Constant Therapy Health, NeuronUP SL and SCHUHFRIED GmbH
Scope of the Study
Market Segments Covered in the Report:
By Component- Neurorehabilitation Therapy
- Neurocognitive Assessment Testing
- Rehab Centers
- Hospital & Clinics
- Homecare Settings
- Physiotherapy Centers
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Cambridge Cognition Holdings plc
- Cognifit, Inc.
- Cogstate Ltd.
- Lumos Labs, Inc. (Lumosity)
- CNS Vital Signs, LLC
- Posit Science Corporation
- BrainCheck, Inc.
- Constant Therapy Health
- NeuronUP SL
- SCHUHFRIED GmbH
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Asia Pacific Neurocognitive Assessment And Rehabilitation Market by Component
Chapter 5. Asia Pacific Neurocognitive Assessment And Rehabilitation Market by Providers
Chapter 6. Asia Pacific Neurocognitive Assessment And Rehabilitation Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- Cambridge Cognition Holdings plc
- Cognifit, Inc.
- Cogstate Ltd.
- Lumos Labs, Inc. (Lumosity)
- CNS Vital Signs, LLC
- Posit Science Corporation
- BrainCheck, Inc.
- Constant Therapy Health
- NeuronUP SL
- SCHUHFRIED GmbH
Methodology
LOADING...
